[Medical treatment of acute arterial obliteration in the limbs].
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D007511:Ischemia; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D010630:Phenindione / Q000627:therapeutic use*; D011150:Popliteal Artery; D013806:Theophylline / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D009539:Nicotinic Acids; D014665:Vasodilator Agents; D010630:Phenindione; D006493:Heparin; D013806:Theophylline; D010208:Papaverine
Le traitement médical des oblitérations artérielles aiguës des membres.